En
Email
  • bovine serum albumin elisa 1
  • bovine serum albumin elisa 1

BlueGene Biotech Human Ischemia Modified Albumin ELISA kit

E01I0394 Human Ischemia Modified Albumin ELISA kit

The Human Ischemia Modified Albumin ELISA kit can be used to identify samples from the human species. Ischemia Modified Albumin can also be called IMA.

Specifications of Human Ischemia Modified Albumin ELISA kit

Product Information

Cat. No.

E01I0394

Product Name

Human Ischemia Modified Albumin ELISA kit

Species

Human

Product Size

48 Tests / 96 Tests

Concentration

50-1000 ng/ml

Sensitivity

1.0 ng/ml

Principal

Competitive ELISA

Sample Volume

100 ul

Sample Type

Serum, plasma, cell culture supernatants, body fluid and tissue homogenate

Assay Time

90 minutes

Platform

Microplate Reader

Conjugate

HRP

Detection Method

Colorimetric

Storage

2-8°C


Kit Components

MATERIALS

SPECIFICATION

QUANTITY

MICROTITER PLATE

96 wells

stripwell

ENZYME CONJUGATE

6.0 mL

1 vial

STANDARD A (0.5mL)

0 ng/mL

1 vial

STANDARD B (0.5mL)

50 ng/mL

1 vial

STANDARD C (0.5mL)

100 ng/mL

1 vial

STANDARD D (0.5mL)

250 ng/mL

1 vial

STANDARD E (0.5mL)

500 ng/mL

1 vial

STANDARD F (0.5mL)

1000 ng/mL

1 vial

SUBSTRATE A

6 mL

1 vial

SUBSTRATE B

6 mL

1 vial

STOP SOLUTION

6 mL

1 vial

WASH SOLUTION (100 x)

10 mL

1 vial

BALANCE SOLUTION

3 mL

1 vial


Principle of the Assay

IMA ELISA kit uses an anti-IMA antibody and an IMA-HRP conjugate in a competitive enzyme immunoassay method. IMA-HRP conjugate is incubated with the assay sample and buffer in a pre-coated plate for one hour. The wells are decanted and washed five times when the incubation period is over. The HRP enzyme substrate is then incubated in the wells. The result of the enzyme-substrate reaction is a complex that is blue in hue. The process is finally stopped by adding a stop solution, causing the solution to turn yellow. In a microplate reader, the color intensity is measured spectrophotometrically at 450 nm. Due to competition for the anti-IMA antibody binding site between IMA from samples and IMA-HRP conjugate, the intensity of the color is inversely proportional to the concentration of IMA. Since the number of sites is limited, as more sites are occupied by IMA from the sample, fewer sites are left to bind IMA-HRP conjugate. A standard curve is plotted relating the intensity of the color (O.D.) to the concentration of standards. The IMA concentration in each sample is interpolated from this standard curve.


Quality Control on Human Ischemia Modified Albumin ELISA kit

Coefficient of Variance

Intra Variation% <10%

Inter Variation% <12%

Recovery

95-102%

Linearity

Diluent Ratio

Range %

1:2

93-105

1:4

88-106

1:8

86-108

Specificity/Cross-reactivity

No significant cross-reactivity or interference between IMA and analogues was observed.


BlueGene Biotech Product Show

Summary of the Assay Procedure for Human Ischemia Modified Albumin ELISA kit

Summary of the Assay Procedure for Human Ischemia Modified Albumin ELISA kit

Citations of Human Ischemia Modified Albumin ELISA kit

E01I0394 has been referenced in the below publications:

Effect of ischemic postconditioning on myocardial injury in patients undergoing cardiac valve replacement under cardiopulmonary bypass.

Investigation on the complementation significance of combined cTnI,IMA and hs-CRP determination in coronary heart disease.

Related Bluegene Biotech Products

Join us and become BlueGene's distributor, you will get a broad range of Life science research products and more than 12 years of experienced technical supports.